封面
市场调查报告书
商品编码
1575773

全球 Omega-3 PUFA 市场 - 2024-2031

Global Omega-3 PUFA Market - 2024-2031

出版日期: | 出版商: DataM Intelligence | 英文 219 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

2023 年,全球 omega-3 PUFA 市场达到 24 亿美元,预计到 2031 年将达到 44 亿美元,2024-2031 年预测期间复合年增长率为 7.9%。

由于消费者意识的不断增强以及对改善健康的营养素的需求,Omega-3 多元不饱和脂肪酸 (PUFA) 市场正在迅速扩大。关键的Omega-3 脂肪酸,包括α-亚麻油酸(ALA)、二十碳五烯酸(EPA) 和二十二碳六烯酸(DHA),因其抗发炎、心血管和认知功效而受到重视。全球可支配收入的增加,特别是在亚洲等发展中经济体,健康意识不断增强的消费者行为正在增加,支持了这一趋势。

最近的趋势显示 Omega-3 来源和产品日益多样化。 Omega-3 传统上源自富含脂肪的鱼类,现在有多种形式可供选择,包括亚麻仁油和奇亚籽油等植物替代品,以满足纯素食和素食消费者的需求。此外,基于藻类的补充剂的进步扩大了市场供应,为获取这些必需营养素提供了更多选择。这种多样化符合将健康益处融入日常食品和补充剂的更广泛趋势。

2023 年 9 月,全球藻类饲料成分领导者 Corbion 推出了 AlgaPrime DHA P3,这是一种突破性的 omega-3 成分,旨在增强宠物食品营养。该新产品显着提高了 DHA(二十二碳六烯酸)水平,提供了一种高性能解决方案,可减少对海洋资源的依赖并降低宠物食品的碳足迹。

市场动态

婴儿营养的需求不断增加

《当前营养发展》中的这项研究着眼于母亲在怀孕期间服用二十二碳六烯酸 (DHA) 时婴儿的身体组成会发生什么变化。具体来说,该研究着眼于脂肪量(FM)和妊娠期体重增加(GWG)。新生儿生长和肥胖研究 (GAINS) 包括 ADORE 试验中的 250 名受试者,结果发现产前 DHA 会增加婴儿脂肪量,而不会改变母亲的 GWG。结果在不同性别之间是一致的,并且在 24 个月的追踪中持续存在,这表明需要进一步研究长期影响。

对婴儿营养的需求不断增加,特别是在 omega-3 多元不饱和脂肪酸 (PUFA) 领域,反映出人们对产前营养重要性的认识不断增强。随着越来越多的证据表明 Omega-3 PUFA(例如 DHA)对婴儿脂肪分布和整体身体组成的益处,人们开始显着转向加强产前饮食干预。在消费者和医疗保健提供者对从早期阶段优化婴儿健康的兴趣推动下,市场对富含 DHA 的补充剂的需求增加。

越来越多的证据表明 DHA 如何降低儿童肥胖风险并改善婴儿健康状况,导致 omega-3 PUFA 补充剂市场不断增长。这一趋势与更广泛的预防性健康措施和个人化营养策略运动一致。随着正在进行的研究不断验证 omega-3 PUFA 的益处,对此类补充剂的需求预计将增长,从而促进该行业的创新和增加投资。

消费者越来越意识到 Omega-3 PUFA 的健康益处

消费者对 omega-3 多元不饱和脂肪酸 (PUFA) 相关健康益处的认识不断增强,推动了 omega-3 PUFA 市场的成长。 Omega-3 PUFA,包括二十碳五烯酸 (EPA) 和二十二碳六烯酸 (DHA),因其在减少发炎、增强心血管健康和支持认知功能方面的作用而广受好评。意识的提高正在影响消费者的偏好和行为,特别是对于寻求透过膳食补充剂来提高表现和恢復的运动员和具有健康意识的个人。

随着越来越多的人寻求将这些有益脂肪纳入饮食中,omega-3 PUFA 的市场正在扩大。人们越来越认识到 omega-3 对健康的正面影响、减少发炎的功效以及改善运动表现和恢復的潜力,这是这一趋势的驱动因素。因此,富含 omega-3 PUFA 的补充剂和功能性食品的市场不断增长,满足了消费者对健康促进产品不断增长的需求。

永续性和环境议题

二十碳五烯酸(EPA)、二十二碳五烯酸(DPA) 和二十二碳六烯酸(DHA) 是三种重要的omega-3 长链多元不饱和脂肪酸(LC-PUFA) ,对人类健康和营养非常重要。传统上,这些营养物质来自海鱼、磷虾和藻类。然而,这些海洋资源的可用性要么停滞不前,要么正在下降,带来了重大的可持续性挑战。

根据 MDPI,为了满足对 ω3 LC-PUFA 不断增长的需求而过度捕捞野生海洋物种已导致严重的环境影响。此外,到 2100 年,气候变迁可能导致全球 DHA 水准下降 10% 至 58%,这主要是由于微藻的可用性减少,而微藻是海洋食物链中 ω3 LC-PUFA 的基本来源。这种情况加剧了海洋生态系统的压力,并导致鱼类资源减少。

水产养殖提供了 ω3 LC-PUFA 野生捕捞的替代方案,但它取决于这些营养物质的可持续供应。养殖鱼类对海洋 ω3 LC-PUFA 来源的依赖限制了水产养殖有效解决野生鱼类族群枯竭问题的潜力。因此,其营养来源的可用性和环境影响限制了水产养殖的可持续性。

目录

第 1 章:方法与范围

第 2 章:定义与概述

第 3 章:执行摘要

第 4 章:动力学

  • 影响因素
    • 司机
      • 婴儿营养的需求不断增加
      • 消费者越来越认识到 omega-3 PUFA 的健康益处
    • 限制
      • 永续性和环境议题
  • 机会
  • 影响分析

第 5 章:产业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析
  • 俄乌战争影响分析
  • DMI 意见

第 6 章:按来源

  • 海洋资源
    • 鱼油
    • 磷虾油
    • 海藻油
    • 其他油类
  • 植物来源
    • 亚麻仁油
    • 奇亚籽油
    • 大麻油
    • 其他油类

第 7 章:按类型

  • α-亚麻油酸 (ALA)
  • 二十二碳六烯酸 (DHA)
  • 二十碳五烯酸 (EPA)

第 8 章:按申请

  • 食品和饮料
  • 膳食补充剂
  • 药品
  • 其他应用

第 9 章:按地区

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 亚太其他地区
  • 中东和非洲

第 10 章:竞争格局

  • 竞争场景
  • 市场定位/份额分析
  • 併购分析

第 11 章:公司简介

  • Cargill, Incorporated.
    • 公司概况
    • 产品组合和描述
    • 财务概览
    • 主要进展
  • DSM
  • Corbion
  • Croda International Plc
  • ADM
  • Arista Industries, Inc.
  • Omega Protein Corporation
  • Goerlich Pharma GmbH
  • Evonik
  • Nu-Mega Ingredients (*LIST NOT EXHAUSTIVE)

第 12 章:附录

简介目录
Product Code: FB553

Overview

Global omega-3 PUFA Market reached US$ 2.4 billion in 2023 and is expected to reach US$ 4.4 billion by 2031, growing with a CAGR of 7.9% during the forecast period 2024-2031.

Due to growing consumer awareness and demand for nutrients that improve health, the Omega-3 Polyunsaturated Fatty Acids (PUFAs) market is expanding rapidly. Key Omega-3s, including Alpha-Linolenic Acid (ALA), Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA), are valued for their anti-inflammatory, cardiovascular and cognitive benefits. Increased disposable incomes worldwide, particularly in developing economies like Asia where health-conscious consumer behavior is on the rise, are supporting the trend.

Recent trends indicate a growing diversification in Omega-3 sources and products. Traditionally sourced from fatty fish, Omega-3s are now available in a variety of forms, including plant-based alternatives like flaxseed and chia seed oils, catering to vegan and vegetarian consumers. Furthermore, advancements in algae-based supplements have broadened market offerings, providing additional options for obtaining these essential nutrients. The diversification aligns with the broader trend of incorporating health benefits into everyday foods and supplements.

In September 2023, Corbion, a global leader in algae-based feed ingredients, introduced AlgaPrime DHA P3, a groundbreaking omega-3 ingredient designed to enhance pet food nutrition. The new product significantly boosts DHA (docosahexaenoic acid) levels, offering a high-performance solution that reduces reliance on marine sources and lowers the carbon footprint of pet food products.

Market Dynamics

Increasing Demand for Infant Nutrition

The study in Current Developments in Nutrition looks at what happens to a baby's body composition when docosahexaenoic acid (DHA) is given to the mother during pregnancy. Specifically, the study looks at fat mass (FM) and gestational weight gain (GWG). The Growth and Adiposity in Newborns Study (GAINS), which included 250 people from the ADORE trial, found that prenatal DHA increases baby fat mass by a lot without changing the GWG of the mother. The results were consistent across sexes and persisted through a 24-month follow-up, reinforcing the need for further research on long-term effects.

The increasing demand for infant nutrition, particularly in the omega-3 polyunsaturated fatty acids (PUFA) sector, reflects a growing awareness of the importance of prenatal nutrition. As evidence mounts regarding the benefits of omega-3 PUFAs, such as DHA, on infant fat distribution and overall body composition, there is a notable shift towards enhancing prenatal dietary interventions. It has resulted in an increased market demand for DHA-enriched supplements, driven by both consumer and healthcare provider interest in optimizing infant health from an early stage.

The growing body of evidence showing how DHA reduces the risk of childhood obesity and improves infant health outcomes is causing the market for omega-3 PUFA supplements to grow. The trend aligns with a broader movement towards preventative health measures and personalized nutrition strategies. As ongoing studies continue to validate the benefits of omega-3 PUFAs, the demand for such supplements is expected to grow, prompting innovation and increased investment in the sector.

Growing Consumer Awareness Of The Health Benefits Of Omega-3 PUFAs

Consumer awareness of the health benefits associated with omega-3 polyunsaturated fatty acids (PUFAs) has been increasing, driving growth in the omega-3 PUFA market. Omega-3 PUFAs, including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are well-regarded for their roles in reducing inflammation, enhancing cardiovascular health and supporting cognitive function. Increased awareness is influencing consumer preferences and behaviors, particularly among athletes and health-conscious individuals seeking to improve performance and recovery through dietary supplements.

The market for omega-3 PUFAs is expanding as more individuals seek to incorporate these beneficial fats into their diets. Increased awareness of omega-3s' positive effects on health, their efficacy in reducing inflammation, and their potential to improve athletic performance and recovery are the trends driving factors. As a result, there is a growing market for supplements and functional foods enriched with omega-3 PUFAs, catering to the rising consumer demand for health-promoting products.

Sustainability and Environmental Concerns

Eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), and docosahexaenoic acid (DHA) are three important omega-3 long-chain polyunsaturated fatty acids (LC-PUFA) that are very important for human health and nutrition. Traditionally, these nutrients are sourced from marine fish, krill and algae. However, the availability of these marine resources is either stagnant or on the decline, presenting significant sustainability challenges.

As per MDPI, the overfishing of wild marine species to meet the growing demand for ω3 LC-PUFA has led to substantial environmental impacts. Furthermore, climate change threatens to diminish global DHA levels by 10 to 58% by 2100, primarily due to the reduced availability of microalgae, the fundamental source of ω3 LC-PUFA in the marine food chain. The situation exacerbates the strain on marine ecosystems and contributes to the decline of fish stocks.

Aquaculture offers an alternative to wild fishing for ω3 LC-PUFA, yet it depends on the sustainable provision of these nutrients. The reliance on marine-based ω3 LC-PUFA sources for farmed fish limits the potential of aquaculture to address the depletion of wild fish populations effectively. Thus, the availability and environmental impact of its nutrient sources limit the sustainability of aquaculture.

Segment Analysis

The global omega-3 PUFA market is segmented based on source, type, application and region.

The Surging Demand for Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA)

News Medical Life Sciences reports that a new study on omega-3 fatty acids, specifically docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), shows that they may help treat acne. This is in line with a larger trend of rising consumer demand for these compounds. Research highlights the anti-inflammatory properties of DHA and EPA, showing that these omega-3 fatty acids may help reduce acne severity. It aligns with the growing consumer awareness of the health benefits of omega-3 fatty acids, which is driving increased demand for these ingredients in dietary supplements and functional foods.

In addition, the study's findings on the efficacy of DHA and EPA in treating acne contribute to the expanding applications of these fatty acids in dermatology and skincare. The evidence supporting the use of DHA and EPA for skin health is fueling market growth as consumers seek products that offer these benefits. The trend is part of a broader movement towards preventive health and wellness, with individuals increasingly turning to dietary supplements to support overall well-being, including skin health.

Geographical Penetration

Rising Demand for Omega-3 PUFA in North America

North America is expected to be the dominant region in the global omega-3 PUFA market holding an approximate market share of 35% during the forecast period. The partnership between DSM-Firmenich and SCN BestCo represents a pivotal moment in the evolution of omega-3 polyunsaturated fatty acids (PUFAs) within the North American market. Fish oil soft gels have historically dominated the market, but despite their effectiveness, they came with drawbacks like a fishy aftertaste, large capsule size, and environmental issues related to overfishing.

As consumer awareness of omega-3 benefits for heart health, cognitive function and overall wellness grew, so did the demand for more palatable and sustainable alternatives. In response to increasing consumer demand for plant-based and environmentally friendly options, the market began to shift towards algal-based omega-3 supplements. The products offered a sustainable, vegetarian-friendly alternative to traditional fish oil, addressing concerns about overfishing and the ecological impact of omega-3 production.

In March 2024, the collaboration between dsm-Firmenich and SCN BestCo is a direct response to these evolving consumer preferences. By leveraging dsm-Firmenich's life's OMEGA O33-P100, an algal-based omega-3 powder, the partnership has successfully developed high-load omega-3 gummies. The gummies provide over 400 mg of EPA and DHA per two-piece serving, significantly surpassing the typical dosage levels found in traditional omega-3 gummies.

Competitive Landscape

The major global players in the market include Cargill, Incorporated, DSM, Corbion, Croda International Plc, ADM, Arista Industries, Inc., Omega Protein Corporation, Goerlich Pharma GmbH, Evonik and Nu-Mega Ingredients.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine war has significantly impacted the omega-3 polyunsaturated fatty acids (PUFA) market. The conflict has disrupted supply chains and increased production costs due to rising prices of raw materials and logistics challenges. The war has also led to economic instability in the region, affecting consumer purchasing power and demand for omega-3 PUFA products.

Furthermore, the sanctions imposed on Russia have complicated trade relationships, limiting access to key markets and affecting the overall availability of omega-3 PUFA products in the region. As a result, the market is experiencing uncertainty and volatility, with companies needing to adapt to the rapidly changing geopolitical landscape.

By Source

Marine Sources

Fish Oil

Krill Oil

Algae Oil

Other Oils

Plant Sources

Flaxseed Oil

Chia Seed Oil

Hemp Oil

Other Oils

By Type

Alpha linoleic acid (ALA)

Docosahexaenoic acid (DHA)

Eicosapentaenoic acid (EPA)

By Application

Food and Beverages

Dietary Supplements

Pharmaceuticals

Other Applications

By Region

North America

US

Canada

Mexico

Europe

Germany

UK

France

Italy

Spain

Rest of Europe

South America

Brazil

Argentina

Rest of South America

Asia-Pacific

China

India

Japan

Australia

Rest of Asia-Pacific

Middle East and Africa

Key Developments

In April 2024, FrieslandCampina introduced two innovative DHA ingredients, Biotis DHA FlexP 15 and Biotis DHA FlexP 20, tailored for the adult nutrition market. The high-load, algae-based, microencapsulated DHA powders are designed for vegan and vegetarian formulations, offering exceptional sensory qualities.

In March 2024, Epax introduced EPAX Omega 3-9-11, the first concentrated oil combining long-chain monounsaturated fatty acids (LC-MUFAs) and long-chain polyunsaturated fatty acids (LC-PUFAs), derived from North Atlantic pelagic fish. The innovative product, rich in Omega-3 (EPA and DHA), Omega-9 and Omega-11 is developed using Epax EQP+ Tech, a specialized distillation process enhancing fatty acid content.

In January 2024, Ritual introduced its Omega-3 DHA + EPA supplement, offering a 500 mg dose of omega-3 fatty acids in a 2:1 DHA to EPA ratio. Sourced sustainably from microalgae in La Foret-Fouesnant, France, the supplement is produced using patented technology to minimize oxidation and reduce burp-back, with natural citrus oil added for improved taste.

Why Purchase the Report?

To visualize the global omega-3 PUFA market segmentation based on source, type, application and region as well as understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development.

Excel data sheet with numerous data points of the omega-3 PUFA market with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping available as Excel consisting of key products of all the major players.

The global omega-3 PUFA market report would provide approximately 62 tables, 53 figures and 219 pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Source
  • 3.2. Snippet by Type
  • 3.3. Snippet by Application
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Demand for Infant Nutrition
      • 4.1.1.2. Growing consumer awareness of the health benefits of omega-3 PUFAs
    • 4.1.2. Restraints
      • 4.1.2.1. Sustainability and Environmental Concerns
  • 4.2. Opportunity
  • 4.3. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. By Source

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 6.1.2. Market Attractiveness Index, By Source
  • 6.2. Marine Sources*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 6.2.3. Fish Oil
    • 6.2.4. Krill Oil
    • 6.2.5. Algae Oil
    • 6.2.6. Other Oils
  • 6.3. Plant Sources
    • 6.3.1. Flaxseed Oil
    • 6.3.2. Chia Seed Oil
    • 6.3.3. Hemp Oil
    • 6.3.4. Other Oils

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. Alpha linoleic acid (ALA)*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Docosahexaenoic acid (DHA)
  • 7.4. Eicosapentaenoic acid (EPA)

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Food and Beverages*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Dietary Supplements
  • 8.4. Pharmaceuticals
  • 8.5. Other Applications

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. US
      • 9.2.6.2. Canada
      • 9.2.6.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. UK
      • 9.3.6.3. France
      • 9.3.6.4. Italy
      • 9.3.6.5. Spain
      • 9.3.6.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Brazil
      • 9.4.6.2. Argentina
      • 9.4.6.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. Australia
      • 9.5.6.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. Cargill, Incorporated.*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
  • 11.2. DSM
  • 11.3. Corbion
  • 11.4. Croda International Plc
  • 11.5. ADM
  • 11.6. Arista Industries, Inc.
  • 11.7. Omega Protein Corporation
  • 11.8. Goerlich Pharma GmbH
  • 11.9. Evonik
  • 11.10. Nu-Mega Ingredients (*LIST NOT EXHAUSTIVE)

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us